Cannabis in Nepal and scopes of its re-legalization


Cannabis in Nepal and scopes of its re-legalization


Niranjan Aryal*1, Roshan Adhikari1

Socal Cannabis Science Research Group (ScCSRG), Los Angeles, California; 1Equal contribution


American Journal of Agricultural Research

The inception of legalization of Cannabis in America has paved way for the extensive research on this medicinal and religious plant all over the world. Despite the long relationship of Nepalese community with Cannabis since time immemorial, where it used to be used for both medical as well as recreational purposes, its illegalization during 1970s led to significant drop in one of the major source of income for numerous household and their families thereby impacting GDP of the country. Due to the geographical diversity of Nepal with most parts covered by hills and mountains along with the fertile land of plain region, the country has been a home to many landraces of Cannabis and we believe that it has the potential to be one of the major hub of harvest of Cannabis and Cannabis derived pharmaceutical industry. In this review, we have focused on the native strains of Cannabis in Nepal which are sold in the markets all over the world legally and how the legalization of Cannabis would bring remarkable upgrade to the country reeling under low economy and would be a great boost for the country to rise above its status of developing country. Apart from this, we have also proposed the steps that have to be taken at the government level for the stepwise legalization, substantial growth of the native strains and be a major leader in the world market by the export of Cannabis and its derived products.


Keywords: Cannabis; Legalization in Nepal; Cannabis landraces in Nepal; Nepalese economy; Cannabis and Hindu Culture.

Free Full-text PDF


How to cite this article:

Niranjan Aryal, Roshan Adhikari. Cannabis in Nepal and scopes of its re-legalization. American Journal of Agricultural Research, 2019,4:47. DOI: 10.28933/ajar-2019-04-1507


References:

1. Blasco-Benito, S., M. Seijo-Vila, M. Caro-Villalobos, I. Tundidor, C. Andradas, E. García-Taboada, J. Wade, S. Smith, M. Guzmán, E. Pérez-Gómez, M. Gordon, and C. Sánchez. 2018. ‘Appraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer’, Biochem Pharmacol, 157: 285-93.
2. Gupta, B. D., C. B. Jani, and P. H. Shah. 2001. ‘Fatal ‘Bhang’ poisoning’, Med Sci Law, 41: 349-52.
3. Luo, X., M. A. Reiter, L. d’Espaux, J. Wong, C. M. Denby, A. Lechner, Y. Zhang, A. T. Grzybowski, S. Harth, W. Lin, H. Lee, C. Yu, J. Shin, K. Deng, V. T. Benites, G. Wang, E. E. K. Baidoo, Y. Chen, I. Dev, C. J. Petzold, and J. D. Keasling. 2019. ‘Complete biosynthesis of cannabinoids and their unnatural analogues in yeast’, Nature, 567: 123-26.
4. Pacher, P. 2013. ‘Towards the use of non-psychoactive cannabinoids for prostate cancer’, Br J Pharmacol, 168: 76-8.
5. Pertwee, R. G. 2008. ‘The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin’, Br J Pharmacol, 153: 199-215.
6. Pollastro, F., A. Minassi, and L. G. Fresu. 2018. ‘Cannabis Phenolics and their Bioactivities’, Curr Med Chem, 25: 1160-85.
7. Sales, A. J., M. V. Fogaça, A. G. Sartim, V. S. Pereira, G. Wegener, F. S. Guimarães, and S. R. L. Joca. 2018. ‘Cannabidiol Induces Rapid and Sustained Antidepressant-Like Effects Through Increased BDNF Signaling and Synaptogenesis in the Prefrontal Cortex’, Mol Neurobiol.
8. Sawler, J., J. M. Stout, K. M. Gardner, D. Hudson, J. Vidmar, L. Butler, J. E. Page, and S. Myles. 2015. ‘The Genetic Structure of Marijuana and Hemp’, PLoS One, 10: e0133292.
9. Shrestha, N. M. 1992. ‘Alcohol and drug abuse in Nepal’, Br J Addict, 87: 1241-8.
10. van Bakel, H., J. M. Stout, A. G. Cote, C. M. Tallon, A. G. Sharpe, T. R. Hughes, and J. E. Page. 2011. ‘The draft genome and transcriptome of Cannabis sativa’, Genome Biol, 12: R102.